Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
- Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
ON-DEMAND WEBINARS
Watch as presenters from Medidata dive into the most common roadblocks customers face when adopting a modern CTMS—and how to avoid them.
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
Discover how a new ActiGraph–Indivi partnership is enhancing neurology clinical trials with digital health technologies that enable more sensitive, real-world outcome measures.
Watch as experts from eClinical Solutions and Medidata delve into end-of-study process challenges, the transition to electronic distribution and management, the advantages of leveraging a digital platform, and more.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Patient-Centricity: A Progressive Prescription For Modern Healthcare]( "eCOA And Digital Platforms Reduce Diabetes Study Startup To 8 Weeks")
eCOA And Digital Platforms Reduce Diabetes Study Startup To 8 WeeksSee how digital solutions came together to enable faster study startup by 50% for this top pharma company conducting a Phase 3 diabetes study within the weight loss market.
-
![GettyImages-1819626829 patient recruitment]( "Connecting The Right Patients To The Right Trial")
Connecting The Right Patients To The Right TrialDirect outreach to potential participants and communication with their healthcare providers is key to boosting trial awareness and participation, thereby achieving recruitment targets.
-
![GettyImages-1292777576 doctor computer]( "Connected Data For Mission-Critical, Time-Sensitive Moments In A Clinical Trial")
Connected Data For Mission-Critical, Time-Sensitive Moments In A Clinical TrialEmbrace the power of a unified eCOA and IRT platform to drive smarter decisions, ensure data accuracy, and boost efficiency across your studies.
-
eCOA/ePRO: Why Patients Deserve Even More Progress
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
-
![GettyImages-1386486759 EDC]( "The Role Of EDC In Real-Time Decision-Making During Adaptive Trials")
The Role Of EDC In Real-Time Decision-Making During Adaptive TrialsAdaptive clinical trials are redefining how research evolves, relying on the ability to capture, clean, and act on data the moment it’s generated.
-
![GettyImages-1357020474-digital-computer-icons-hands-business-working]( "The Founder Behind The Platform")
The Founder Behind The PlatformLearn about the founding and mission of ClinAI, a groundbreaking platform that leverages automation and analytics to enhance vendor selection and management.
-
![GettyImages-2172328990-5-five]( "5 Essential Steps To Implementing Decentralized Clinical Trials Globally")
5 Essential Steps To Implementing Decentralized Clinical Trials GloballyRunning a global decentralized clinical trial requires a strategy that balances the FDA's focus on technology accessibility with the EMA's emphasis on validation and comprehensive documentation.
-
![science drug development data iStock-1209661917]( "How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?")
How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?
-
![Leadership-management-teamwork-GettyImages-1419530650]( "Improve Clinical Trial Management With Automated CTMS Tools")
Improve Clinical Trial Management With Automated CTMS ToolsUncover how advancements in clinical trial management systems signify a shift towards more streamlined and effective trial management and an enhanced quality and pace of medical research.
-
![GettyImages-1320799464 AI]( "How AI And ML Can Transform Clinical Trial Conduct")
How AI And ML Can Transform Clinical Trial ConductThere’s no doubt that 2023 will be remembered as the year that artificial intelligence and machine learning became mainstream. Gain an overview of the uses of AI and ML in clinical conduct.
FROM THE EDITOR
- Telehealth In Clinical Trials: What Sites And Patients Think
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
RECENT NEWSLETTERS
- 03.07.26 -- February's Best In Clinical Tech — AI, eTMF & More
- 03.05.26 -- Is Your Legacy EDC Holding Back AI In Clinical Trials?
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
